Literature DB >> 26808501

Acidic pH increases airway surface liquid viscosity in cystic fibrosis.

Xiao Xiao Tang, Lynda S Ostedgaard, Mark J Hoegger, Thomas O Moninger, Philip H Karp, James D McMenimen, Biswa Choudhury, Ajit Varki, David A Stoltz, Michael J Welsh.   

Abstract

Cystic fibrosis (CF) disrupts respiratory host defenses, allowing bacterial infection, inflammation, and mucus accumulation to progressively destroy the lungs. Our previous studies revealed that mucus with abnormal behavior impaired mucociliary transport in newborn CF piglets prior to the onset of secondary manifestations. To further investigate mucus abnormalities, here we studied airway surface liquid (ASL) collected from newborn piglets and ASL on cultured airway epithelia. Fluorescence recovery after photobleaching revealed that the viscosity of CF ASL was increased relative to that of non-CF ASL. CF ASL had a reduced pH, which was necessary and sufficient for genotype-dependent viscosity differences. The increased viscosity of CF ASL was not explained by pH-independent changes in HCO3- concentration, altered glycosylation, additional pH-induced disulfide bond formation, increased percentage of nonvolatile material, or increased sulfation. Treating acidic ASL with hypertonic saline or heparin largely reversed the increased viscosity, suggesting that acidic pH influences mucin electrostatic interactions. These findings link loss of cystic fibrosis transmembrane conductance regulator-dependent alkalinization to abnormal CF ASL. In addition, we found that increasing Ca2+ concentrations elevated ASL viscosity, in part, independently of pH. The results suggest that increasing pH, reducing Ca2+ concentration, and/or altering electrostatic interactions in ASL might benefit early CF.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26808501      PMCID: PMC4767348          DOI: 10.1172/JCI83922

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  97 in total

Review 1.  Respiratory tract mucin genes and mucin glycoproteins in health and disease.

Authors:  Mary Callaghan Rose; Judith A Voynow
Journal:  Physiol Rev       Date:  2006-01       Impact factor: 37.312

2.  Inhibition of airway liquid secretion and its effect on the physical properties of airway mucus.

Authors:  L Trout; M King; W Feng; S K Inglis; S T Ballard
Journal:  Am J Physiol       Date:  1998-02

Review 3.  Cystic fibrosis genetics: from molecular understanding to clinical application.

Authors:  Garry R Cutting
Journal:  Nat Rev Genet       Date:  2014-11-18       Impact factor: 53.242

Review 4.  Terminal glycosylation in cystic fibrosis.

Authors:  T F Scanlin; M C Glick
Journal:  Biochim Biophys Acta       Date:  1999-10-08

5.  Oxidation increases mucin polymer cross-links to stiffen airway mucus gels.

Authors:  Shaopeng Yuan; Martin Hollinger; Marrah E Lachowicz-Scroggins; Sheena C Kerr; Eleanor M Dunican; Brian M Daniel; Sudakshina Ghosh; Serpel C Erzurum; Belinda Willard; Stanley L Hazen; Xiaozhu Huang; Stephen D Carrington; Stefan Oscarson; John V Fahy
Journal:  Sci Transl Med       Date:  2015-02-25       Impact factor: 17.956

6.  Elemental composition of airway surface liquid in the pig determined by x-ray microanalysis.

Authors:  Inna Kozlova; Viengphet Vanthanouvong; Birgitta Almgren; Marieann Högman; Godfried M Roomans
Journal:  Am J Respir Cell Mol Biol       Date:  2004-10-15       Impact factor: 6.914

Review 7.  Analysis of N- and O-linked glycans from glycoproteins using MALDI-TOF mass spectrometry.

Authors:  Willy Morelle; Valegh Faid; Frédéric Chirat; Jean-Claude Michalski
Journal:  Methods Mol Biol       Date:  2009

8.  A small molecule CFTR inhibitor produces cystic fibrosis-like submucosal gland fluid secretions in normal airways.

Authors:  Jay R Thiagarajah; Yuanlin Song; Peter M Haggie; A S Verkman
Journal:  FASEB J       Date:  2004-03-04       Impact factor: 5.191

9.  Different O-glycosylation of respiratory mucin glycopeptides from a patient with cystic fibrosis.

Authors:  K A Thomsson; I Carlstedt; N G Karlsson; H Karlsson; G C Hansson
Journal:  Glycoconj J       Date:  1998-08       Impact factor: 2.916

10.  Elemental composition of human airway surface fluid in healthy and diseased airways.

Authors:  L Joris; I Dab; P M Quinton
Journal:  Am Rev Respir Dis       Date:  1993-12
View more
  105 in total

1.  Repurposing tromethamine as inhaled therapy to treat CF airway disease.

Authors:  Mahmoud H Abou Alaiwa; Janice L Launspach; Kelsey A Sheets; Jade A Rivera; Nicholas D Gansemer; Peter J Taft; Peter S Thorne; Michael J Welsh; David A Stoltz; Joseph Zabner
Journal:  JCI Insight       Date:  2016-06-02

2.  Mucus strands from submucosal glands initiate mucociliary transport of large particles.

Authors:  Anthony J Fischer; Maria I Pino-Argumedo; Brieanna M Hilkin; Cullen R Shanrock; Nicholas D Gansemer; Anna L Chaly; Keyan Zarei; Patrick D Allen; Lynda S Ostedgaard; Eric A Hoffman; David A Stoltz; Michael J Welsh; Mahmoud H Abou Alaiwa
Journal:  JCI Insight       Date:  2019-01-10

3.  Acid exposure disrupts mucus secretion and impairs mucociliary transport in neonatal piglet airways.

Authors:  Yan Shin J Liao; Shin Ping Kuan; Maria V Guevara; Emily N Collins; Kalina R Atanasova; Joshua S Dadural; Kevin Vogt; Veronica Schurmann; Laura Bravo; Eda Eken; Mariana Sponchiado; Leah R Reznikov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-11       Impact factor: 5.464

4.  SPX-101 Is a Promising and Novel Nebulized ENaC Inhibitor.

Authors:  Alison Lennox; Mike M Myerburg
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

5.  Gel-forming mucins form distinct morphologic structures in airways.

Authors:  Lynda S Ostedgaard; Thomas O Moninger; James D McMenimen; Nicholas M Sawin; Connor P Parker; Ian M Thornell; Linda S Powers; Nicholas D Gansemer; Drake C Bouzek; Daniel P Cook; David K Meyerholz; Mahmoud H Abou Alaiwa; David A Stoltz; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

6.  CrossTalk opposing view: mucosal acidification does not drive early progressive lung disease in cystic fibrosis.

Authors:  Stephen M Stick; André Schultz
Journal:  J Physiol       Date:  2018-07-17       Impact factor: 5.182

7.  Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.

Authors:  Yinghua Tang; Ziying Yan; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2020-04-15       Impact factor: 5.695

Review 8.  Mucociliary Transport in Healthy and Cystic Fibrosis Pig Airways.

Authors:  Yuliang Xie; Lynda Ostedgaard; Mahmoud H Abou Alaiwa; Lin Lu; Anthony J Fischer; David A Stoltz
Journal:  Ann Am Thorac Soc       Date:  2018-11

9.  Acidic Submucosal Gland pH and Elevated Protein Concentration Produce Abnormal Cystic Fibrosis Mucus.

Authors:  Yuliang Xie; Lin Lu; Xiao Xiao Tang; Thomas O Moninger; Tony Jun Huang; David A Stoltz; Michael J Welsh
Journal:  Dev Cell       Date:  2020-07-29       Impact factor: 12.270

10.  CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes.

Authors:  Benjamin Steines; David D Dickey; Jamie Bergen; Katherine Jda Excoffon; John R Weinstein; Xiaopeng Li; Ziying Yan; Mahmoud H Abou Alaiwa; Viral S Shah; Drake C Bouzek; Linda S Powers; Nicholas D Gansemer; Lynda S Ostedgaard; John F Engelhardt; David A Stoltz; Michael J Welsh; Patrick L Sinn; David V Schaffer; Joseph Zabner
Journal:  JCI Insight       Date:  2016-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.